HIINDIA.COM
South Asian Views On Global News - Update 24X7
ELI

Covid: Favipiravir shows hope in Mumbai trial

BUY-SELL | HELP WANTED | MATRIMONIAL

The current favipiravir trial was conducted from May 3 to July 3 among 150 patients admitted at Breach Candy Hospital on 75 patients and another ‘control group’ received some other drugs. “The median time to cessation of viral shedding was five days versus seven days in the control group,” said the study.

Replica of Print on your device!

CLICK & Send us 'hi' for Free Subscription

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept